http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021226695-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_541216e0930591b1348add361ea90b6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f17e1f3189d876840dec034fe61837f0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f33e04e92bb93277b4ff8e4abb5e945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2d52e97ea915205295c2e5607de0c0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b539766e542ca5a12f64970d370808d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adcab45a3d8e8f6c0696ac6271052f40
publicationDate 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021226695-A1
titleOfInvention Recombinant human antibodies for inhibiting human tissue kallikrein 7 (klk7) and use in diseases related to the process of skin desquamation
abstract The present invention describes compounds that are selective inhibitors of human tissue kallikrein 7 (KLK7), compositions comprising said compounds, a process for producing said compounds and uses thereof. The present invention pertains to the fields of chemistry, pharmacy and medicine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022192647-A1
priorityDate 2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5834290-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016044662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102014027271-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021055577-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012083385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013010963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017065570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10472423-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015112081-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453

Total number of triples: 55.